59,542 Corteva, Inc. $CTVA Shares Sold by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. trimmed its stake in shares of Corteva, Inc. (NYSE:CTVA) by 7.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 753,399 shares of the company’s stock after selling 59,542 shares during the period. Robeco Institutional Asset Management B.V. owned about 0.11% of Corteva worth $63,180,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the stock. Commonwealth Financial Services LLC bought a new position in Corteva during the 3rd quarter worth about $204,000. Sumitomo Mitsui DS Asset Management Company Ltd lifted its holdings in shares of Corteva by 18.6% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 105,013 shares of the company’s stock valued at $8,154,000 after purchasing an additional 16,456 shares in the last quarter. Smithbridge Asset Management Inc. DE lifted its holdings in shares of Corteva by 10.7% in the third quarter. Smithbridge Asset Management Inc. DE now owns 20,700 shares of the company’s stock valued at $1,607,000 after purchasing an additional 2,000 shares in the last quarter. Abel Hall LLC lifted its holdings in shares of Corteva by 20.6% in the third quarter. Abel Hall LLC now owns 5,952 shares of the company’s stock valued at $462,000 after purchasing an additional 1,016 shares in the last quarter. Finally, IFP Advisors Inc boosted its position in shares of Corteva by 19.9% during the third quarter. IFP Advisors Inc now owns 16,680 shares of the company’s stock worth $1,295,000 after buying an additional 2,772 shares during the period. 81.54% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on CTVA shares. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $101.00 price objective on shares of Corteva in a report on Monday, August 3rd. JPMorgan Chase & Co. upgraded Corteva from a “neutral” rating to an “overweight” rating and set a $19.00 target price on the stock in a research note on Tuesday, October 6th. Bank of America boosted their target price on Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a research note on Monday, July 20th. UBS Group reduced their price target on Corteva to $15.00 and set a “neutral” rating for the company in a research report on Monday, October 12th. Finally, Oppenheimer set a $17.00 price target on shares of Corteva in a research note on Monday, October 5th. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $60.59.

Corteva Trading Up 1.2%

Corteva stock opened at $12.87 on Friday. The company has a market cap of $8.59 billion, a price-to-earnings ratio of 8.52, a P/E/G ratio of 1.78 and a beta of 0.57. The firm has a 50-day moving average of $60.00 and a 200-day moving average of $73.83. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. Corteva, Inc. has a one year low of $11.74 and a one year high of $90.97.

Corteva (NYSE:CTVA) last released its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%. The business had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. During the same quarter in the previous year, the business earned $2.20 earnings per share. Corteva’s quarterly revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, equities analysts expect that Corteva, Inc. will post 1.04 earnings per share for the current fiscal year.

About Corteva

Corteva, Inc (NYSE: CTVA) is an agriculture company that develops and supplies products and services designed to help farmers improve crop productivity, protect yields and manage agricultural challenges. Its business is organized primarily around seed and crop protection products.

The company’s seed portfolio includes branded corn, soybean, cotton, sunflower, canola and other crop varieties, supported by plant genetics and biotechnology. Its crop protection business offers herbicides, insecticides, fungicides and seed-applied treatments, along with biological and digital agriculture solutions intended to support crop health and farm-management decisions.

Corteva was formed through the separation of the agriculture division of DowDuPont and became an independent public company in 2019.